Detalles de la búsqueda
1.
Efficacy, Safety, and Tolerability of RBP-7000 Once-Monthly Risperidone for the Treatment of Acute Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study.
J Clin Psychopharmacol
; 36(2): 130-40, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26862829
2.
Sustained-Release Buprenorphine (RBP-6000) Blocks the Effects of Opioid Challenge With Hydromorphone in Subjects With Opioid Use Disorder.
J Clin Psychopharmacol
; 36(1): 18-26, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26650971
3.
Viloxazine in the Management of CNS Disorders: A Historical Overview and Current Status.
CNS Drugs
; 35(6): 643-653, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34003459
4.
Simultaneous determination of buprenorphine, norbuprenorphine and naloxone in human plasma by liquid chromatography/tandem mass spectrometry.
J Pharm Biomed Anal
; 120: 142-52, 2016 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-26730511
5.
Population Pharmacokinetic Modeling After Repeated Administrations of RBP-6000, a New, Subcutaneously Injectable, Long-Acting, Sustained-Release Formulation of Buprenorphine, for the Treatment of Opioid Use Disorder.
J Clin Pharmacol
; 56(7): 806-15, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26479717
6.
Pharmacokinetics of Sublingual Buprenorphine and Naloxone in Subjects with Mild to Severe Hepatic Impairment (Child-Pugh Classes A, B, and C), in Hepatitis C Virus-Seropositive Subjects, and in Healthy Volunteers.
Clin Pharmacokinet
; 54(8): 837-49, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25603822
7.
Population pharmacokinetic modeling and simulation to guide dose selection for RBP-7000, a new sustained-release formulation of risperidone.
J Clin Pharmacol
; 55(1): 93-103, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25043337
8.
A randomized, double-blind, placebo-controlled trial of RBP-8000 in cocaine abusers: pharmacokinetic profile of rbp-8000 and cocaine and effects of RBP-8000 on cocaine-induced physiological effects.
J Addict Dis
; 33(4): 289-302, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25299069
9.
A population pharmacokinetic and pharmacodynamic modelling approach to support the clinical development of RBP-6000, a new, subcutaneously injectable, long-acting, sustained-release formulation of buprenorphine, for the treatment of opioid dependence.
Clin Pharmacokinet
; 53(9): 813-24, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25015174
10.
Population pharmacokinetics and prediction of dopamine D2 receptor occupancy after multiple doses of RBP-7000, a new sustained-release formulation of risperidone, in schizophrenia patients on stable oral risperidone treatment.
Clin Pharmacokinet
; 53(6): 533-43, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24464285
Resultados
1 -
10
de 10
1
Próxima >
>>